542724 EARUM

Earum Pharmaceuticals Share Price Earum Pharmaceuticals

₹2.53
-0.05 (-1.94%)
26 February, 2024 00:11 BSE: 542724 NSE: EARUMISIN: INE060601023

Start SIP in Earum Pharmaceuticals

Start SIP

Earum Pharmaceuticals Performance

Day Range

  • Low 0
  • High 0
₹ 2

52 Week Range

  • Low 0
  • High 0
₹ 2
  • Open Price0
  • Previous Close0
  • Volume

Earum Pharmaceuticals Share Price

  • Over 1 Month 36.76%
  • Over 3 Month 150.5%
  • Over 6 Month 121.93%
  • Over 1 Year 7.2%

Earum Pharmaceuticals Key Statistics

Earum Pharmaceuticals Financials
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr 0022
Operating Expenses Qtr Cr 0120
Operating Profit Qtr Cr 0-1-11
Depreciation Qtr Cr 0000
Interest Qtr Cr 0000
Tax Qtr Cr 0000
Net Profit Qtr Cr 0-101
IndicatorMar 2023
Total Revenue Annual Cr 16
Operating Expenses Annual Cr 13
Operating Profit Annual in Cr 1
Depreciation Cr 0
Interest Annual Cr 0
Tax Annual Cr 1
Net Profit Annual Cr 2
IndicatorMar 2023
Cash from Operating Activity Annual Cr 0
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr 0
Net Cash Flow Annual Cr 0
IndicatorMar 2023
Total ShareHolders Funds Annual Cr 19
Fixed Assets Annual Cr 0
Total Non Current Assets Annual Cr 0
Total Current Assets Annual Cr 28
Total Assets Annual Cr 29
IndicatorMar 2023
Book Value Per Share Annual Rs 3
ROE Annual % 11
ROCE Annual % 16
Total Debt to Total Equity Annual -
EBDIT Annual Margin % 23
IndicatorDec 2023Sep 2023Jun 2023Mar 2023
Oper Rev Qtr Cr
Operating Expenses Qtr Cr
Operating Profit Qtr Cr
Depreciation Qtr Cr
Interest Qtr Cr
Tax Qtr Cr
Net Profit Qtr Cr
IndicatorMar 2023
Total Revenue Annual Cr
Operating Expenses Annual Cr
Operating Profit Annual in Cr
Depreciation Cr
Interest Annual Cr
Tax Annual Cr
Net Profit Annual Cr
IndicatorMar 2023
Cash from Operating Activity Annual Cr
Cash from Investing Activity Annual Cr
Cash from Financing Annual Activity Cr
Net Cash Flow Annual Cr
IndicatorMar 2023
Total ShareHolders Funds Annual Cr
Fixed Assets Annual Cr
Total Non Current Assets Annual Cr
Total Current Assets Annual Cr
Total Assets Annual Cr
IndicatorMar 2023
Book Value Per Share Annual Rs
ROE Annual %
ROCE Annual %
Total Debt to Total Equity Annual -
EBDIT Annual Margin %

Earum Pharmaceuticals Technicals

EMA & SMA

Current Price
₹2.53
-0.05 (-1.94%)
pointer
  • Bullish Moving Average
  • ___
  • 9
  • Bearish Moving Average
  • ___
  • 7
  • 20 Day
  • ₹2.57
  • 50 Day
  • ₹2.12
  • 100 Day
  • ₹1.79
  • 200 Day
  • ₹1.81
  • 20 Day
  • ₹2.69
  • 50 Day
  • ₹1.95
  • 100 Day
  • ₹1.49
  • 200 Day
  • ₹1.52

Earum Pharmaceuticals Resistance and Support

PIVOT
₹2.53
Resistance
First Resistance 2.53
Second Resistance 2.53
Third Resistance 2.53
RSI 54.10
MFI 46.55
MACD Single Line 0.28
MACD 0.20
Support
First Resistance 2.53
Second Resistance 2.53
Third Resistance 2.53

Earum Pharmaceuticals Delivery and Volume

Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
Day 711,069 71,106,900 100
Week 501,312 50,131,240 100
1 Month 3,311,023 331,102,319 100
6 Month 3,066,920 290,713,342 94.79

Earum Pharmaceuticals Result Highlights

Earum Pharmaceuticals Synopsis

BSE-Medical-Whlsle Drg/Suppl

Earum Pharmaceutical is involved in the business activities of Manufacture of other chemical products. Company’s Total Operating Revenue is Rs. 14.09 Cr. and Equity Capital is Rs. 12.34 Cr. for the Year ended 31/03/2023. Earum Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 26/07/2012 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L24230GJ2012PLC071299 and registration number is 071299.
Market Cap 63
Sales 4
Shares in Float 24.71
No of funds
Yield
Book Value 0.98
U/D Vol ratio 1.9
LTDebt / Equity
Alpha 0.16
Beta 0.07

Earum Pharmaceuticals

Owner NameDec-23Sep-23Jun-23Mar-23
Promoters
Individual Investors 95.34%95.47%63.97%95%
Others 4.66%4.53%36.03%5%

Earum Pharmaceuticals Management

Name Designation
Mr. Vijaykumar Patel Managing Director
Mr. Sanjaykumar Nai Non Executive Director
Mr. Parimal Patwa Independent Director
Mr. Harsh Kothari Independent Director
Mr. Premaram Patel Independent Director

Earum Pharmaceuticals Forecast

Price Estimates

2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)

Other Analyst Rating

Earum Pharmaceuticals Corporate Action

Date Purpose Remarks
2024-02-14 Quarterly Results
2024-01-30 Preferential issue of shares
2023-08-14 Quarterly Results
2023-07-28 Bonus issue & A.G.M.
2023-07-21 F. Dividend, Bonus, Stock Split & Buy Back
Date Purpose Remarks
2021-08-10 Bonus Rs.0.00 issue in the ratio of 1:1 of Rs. 10/-.
Date Purpose Remarks
2021-12-18 Split Rs.0.00 Split from Rs. 10/- to Rs. 2/-.

Earum Pharmaceuticals MF Shareholding

Name Amount(cr)

Earum Pharmaceuticals FAQs

What is Share Price of Earum Pharmaceuticals ?

Earum Pharmaceuticals share price is ₹2 As on 25 February, 2024 | 23:57

What is the Market Cap of Earum Pharmaceuticals ?

The Market Cap of Earum Pharmaceuticals is ₹62.5 Cr As on 25 February, 2024 | 23:57

What is the P/E ratio of Earum Pharmaceuticals ?

The P/E ratio of Earum Pharmaceuticals is -178.8 As on 25 February, 2024 | 23:57

What is the PB ratio of Earum Pharmaceuticals ?

The PB ratio of Earum Pharmaceuticals is 3.3 As on 25 February, 2024 | 23:57

Q2FY23